Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone IVI vs STI for DME during Cataract Surgery
NCT00801450Phase 2Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Sep 2007
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of triamcinolone acetonide in diabetic macular edema (DME) (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Central Subfield Macular Thickness at 24 weeks. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00801450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801450.